Trials / Completed
CompletedNCT00835068
Post Marketing Observational Study of Reformulated BeneFIX
Post Marketing Observational Study Of Reformulated BeneFIX
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 58 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The primary objective of this observational study is to collect safety data on reformulated BeneFIX as prescribed in routine clinical practice conditions in France. The secondary objectives are to collect data on the clinical course of individuals treated with reformulated BeneFIX and on the ease of reformulated BeneFIX.
Detailed description
No sampling
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | As it is a non interventional study, patient receives his usual treatment (BeneFIX) as determined by the physician |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2009-02-03
- Last updated
- 2014-09-17
- Results posted
- 2014-09-17
Locations
17 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00835068. Inclusion in this directory is not an endorsement.